AKT1 and B-cell chronic lymphocytic leukemia: Thus, RL cells differ from CLL due to the lack of MEK➔AKT pathway cross-talk and AKT pathway inhibition alone is able to fully reverse anti-IgM-induced PDCD4 down-regulation.